BioSpace News Archive

CannTrust Holdings Inc. (“CannTrust” or the “Company”, TSX:TRST) is pleased to announce that it has satisfied all the regulatory requirements to list its common shares on the New York Stock Exchange (“NYSE”).

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ:NVCN) (TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve technologies and in the development of minimally invasive devices for the treatment of refractory angina, today provided a corporate and operational update.

ORIC Pharmaceuticals announced that Jacob Chacko, MD, Chief Executive Officer, will host one-on-one investor meetings on Wednesday, February 27 at the 8th Annual SVB Leerink Global Healthcare Conference, held Wednesday, February 27 through Friday, March 1, 2019 at the Lotte New York Palace in New York City.

Vapotherm, Inc. announced that it will release financial results for the fourth quarter and fiscal year 2018 after the close of trading on Tuesday, March 12, 2019.

Phase 1/2 combination clinical trial evaluating Torque’s Deep IL-15 Primed T Cells (TRQ-1501) and KEYTRUDA® (pembrolizumab) for the treatment of multiple cancer indications

Reliq Health Technologies Inc., a technology company that develops innovative mobile health and telemedicine solutions for the community-based healthcare market, announced the formation of its new Medical Advisory Board and the appointment of five inaugural members.

Insmed Incorporated announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at the Leerink Partners 8th Annual Global Healthcare Conference in New York on Wednesday, February 27, 2019 at 3:30 p.m. ET.

Biocept, Inc. announces that President and CEO Michael W. Nall has issued the following letter to stockholders

Will oversee the clinical development and regulatory submissions for company’s extensive pipeline, including two late-stage programs for the treatment of central nervous system disorders

Novus Therapeutics, Inc., a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat, announced that the company will participate at the 8th Annual SVB Leerink Healthcare Conference on Thursday, February 28, 2019 at the Lotte New York Palace, New York.